

Analysts initiated coverage: Neutral on KEEL ($2), Buy on PTN ($12), FRVO ($17) and YARW ($60).
You can purchase shares of Palatin Technologies (NASDAQ:PTN) through any online brokerage.
Other companies in Palatin Technologies’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Palatin Technologies has a consensus price target of $36.00.
The stock price for Palatin Technologies (NASDAQ: PTN) is $6.48 last updated November 6, 2026 at 7:52 PM EST.
There are no upcoming dividends for Palatin Technologies.
Palatin Technologies does not have any upcoming earnings scheduled.
There is no upcoming split for Palatin Technologies.
Palatin Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics...